The National Institutes of Health has agreed in court filings to revisit hundreds of grant applications it previously shelved or denied, reversing a pattern of pre‑2026 rejections tied to the prior administration's funding priorities. A federal court order compelled the agency to take a second look at proposals it set aside. The move follows litigation challenging the administration's discretionary withholding of research funding on policy grounds. Universities and research institutions now anticipate renewed opportunities to secure federal support for projects that had been stalled, though the approvals will be subject to standard peer‑review and compliance checks. Research offices should audit recent unfunded proposals, prioritize resubmission where feasible, and engage sponsored‑research legal counsel to track agency timelines. The development underscores the legal risks agencies face when grant‑making diverges from established scientific review processes.